O. Sugimoto et al. / Tetrahedron 57 (2001) 2133±2138
2137
propanol (9)Lithium n-butanetellurolate (2.20 mmol), 1
461 mg (2.00 mmol), n-butyllithium (2.20 mmol) and ace-
tone 580 mg (10.0 mmol) were used in this reaction to give
344 mg (yield: 68%) of the compound and 12 mg (yield:
3%) of 612 according to the protocol described in general
procedure (condition: rt/10 min). Yellow prisms (recryst.
aromatic-H), 8.50 (1H, d, J5.7 Hz, aromatic-H); Anal.
calcd for C14H17NO: C, 78.10; H, 7.96; N, 6.51. Found: C,
78.12; H, 7.83; N, 6.54.
4.1.13. 2,2-Dimethyl-1-(1,4-diphenyl-1H-pyrazolo[3,4-d]-
pyrimidin-6-yl)-1-propanol (19). Lithium n-butanetelluro-
late (2.20 mmol), 6-chloro-1,4-diphenyl-1H-pyrazolo[3,4-
d]pyrimidine (13) 614 mg (2.00 mmol), n-butyllithium
(2.20 mmol) and pivalaldehyde 861 mg (10.0 mmol) were
used in this reaction to give 370 mg (yield: 52%) of the
compound according to the protocol described in general
procedure (condition: rt/10 min). Pale-yellow needles
1
from hexane±ethyl acetate). Mp 758C. H NMR (CDCl3);
ppm: 1.76 (6H, s, (CH3)2), 4.33 (1H, s, ±OH), 7.32±7.77
(3H, m, phenyl-H), 8.12±8.40 (2H, m, phenyl-H), 8.47 (1H,
s, C3±H), 9.03 (1H, s, C6±H). Anal. calcd for C14H14N4O: C,
66.13; H, 5.55; N, 22.03. Found: C, 66.12; H, 5.38; N, 21.86.
1
4.1.9. 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidine (6). Lithium
n-butanetellurolate (2.20 mmol), 1 461 mg (2.00 mmol),
(recryst. from hexane±ethyl acetate). Mp 1588C. H NMR
t
(CDCl3); ppm: 1.07 (9H, s, Bu), 4.29 (1H, d, J7.7 Hz, ±
n-butyllithium
(2.20 mmol)
and
acetone
580 mg
OH), 4.68 (1H, d, J7.7 Hz, ±CH±), 7.26±7.75 (6H, m,
phenyl-H), 8.09±8.37 (4H, m, phenyl-H), 8.52 (1H, s, C3±
H). Anal. calcd for C22H22N4O: C, 73.72; H, 6.19; N, 15.63.
Found: C, 73.84; H, 6.36; N, 15.48.
(10.0 mmol) were used in this reaction to give 12 mg (yield:
3%) of the compound12 and 344 mg (yield: 68%) of 9 accord-
ing to the protocol described in general procedure (condition:
1
rt/10 min). Pale-yellow solids. Mp 808C (lit. 79±818C). H
NMR (CDCl3); ppm: 7.30±7.70 (3H, m, phenyl-H), 8.11±
8.40 (2H, m, phenyl-H), 8.32 (1H, s, C3±H), 9.13 (1H, s,
C6±H), 9.27 (1H, s, C4±H).
4.1.14.
2,2-Dimethyl-1-(4-phenylquinazolin-2-yl)-1-
propanol (20). Lithium n-butanetellurolate (2.20 mmol),
2-chloro-4-phenylquinazoline (14) 481 mg (2.00 mmol),
n-butyllithium (2.20 mmol), and pivalaldehyde 861 mg
(10.0 mmol) were used in this reaction to give 366 mg
(yield: 63%) of the compound according to the protocol
described in general procedure (condition: rt/10 min).
White needles (recryst. from hexane±ethyl acetate). Mp
120±1218C. H NMR (CDCl3); ppm: 1.05 (9H, s, Bu),
4.42 (1H, d, J7.7 Hz, ±OH), 4.72 (1H, d, J7.7 Hz, ±
CH±), 7.40±8.24 (9H, m, aromatic-H); Anal. calcd for
C19H20N2O: C, 78.05; H, 6.89; N, 9.58. Found: C, 78.00;
H, 6.90; N, 9.66.
4.1.10. 2-(1-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-
3-buten-2-ol (10). Lithium n-butanetellurolate (2.20
mmol), 1 461 mg (2.00 mmol), n-butyllithium (2.20
mmol) and 3-buten-2-one 700 mg (10.0 mmol) were used
in this reaction to give 255 mg (yield: 48%) of the
compound and 90 mg (yield: 23%) of 6 according to the
protocol described in general procedure (condition: rt/
10 min). White powder (recryst. from hexane±ethyl ace-
1
t
1
tate). Mp 65±668C. H NMR (CDCl3); ppm: 1.84 (3H, s,
CH3), 4.63 (1H, s, ±OH), 5.28 (1H, dd, J10.4, 0.9 Hz,
alkene-H), 5.56 (1H, dd, J17.1, 0.9 Hz, alkene-H), 6.33
(1H, dd, J17.1, 10.4 Hz, alkene-H), 7.31±7.71 (3H, m,
phenyl-H), 8.12±8.33 (2H, m, phenyl-H), 8.44 (1H, s, C3±
H), 9.03 (1H, s, C6±H); Anal. calcd for C15H14N4O: C,
67.65; H, 5.30; N, 21.04. Found: C, 67.51; H, 5.30; N, 20.78.
4.1.15. 2,20-Biquinoxalinyl (21). Lithium n-butanetelluro-
late (2.20 mmol), 2-chloroquinoxaline (15) 329 mg
(2.00 mmol), n-butyllithium (2.20 mmol) and pivalalde-
hyde 861 mg (10.0 mmol) were used in this reaction to
give 95 mg (yield: 36%) of the compound13 according to
the protocol described in general procedure (condition: rt/
1
4.1.11. 2,2-Dimethyl-1-(2-quinolinyl)-1-propanol (17).
Lithium n-butanetellurolate (2.20 mmol), 2-bromoquinoline
(11) 416 mg (2.00 mmol), n-butyllithium (2.20 mmol) and
pivalaldehyde 861 mg (10.0 mmol) were used in this reac-
tion to give 323 mg (yield: 75%) of the compound according
to the protocol described in general procedure (condition:
re¯ux/43 h). Pale-yellow plates (recryst. from hexane±ethyl
acetate). Mp 73±758C. 1H NMR (CDCl3); ppm: 0.98 (9H, s,
tBu), 4.20±5.10 (1H, br, ±OH), 4.53 (1H, brs, ±CH±),
7.14±7.95 (4H, m, aromatic-H), 8.09 (2H, d, J8.4 Hz,
aromatic-H); Anal. calcd for C14H17NO: C, 78.10; H,
7.96; N, 6.51. Found: C, 78.00; H, 7.99; N, 6.58.
10 min). Dark-red solids. Mp 2728C (lit. 2748C). H NMR
(CDCl3); ppm: 7.76±8.06 (4H, m, aromatic-H), 8.11±8.42
0
(4H, m, aromatic-H), 10.13 (2H, s, C3 and C3 ±H).
4.1.16. 4,40-Biquinazolinyl (22). Lithium n-butanetelluro-
late (2.20 mmol), 4-chloroquinazoline (16) 329 mg
(2.00 mmol), n-butyllithium (2.20 mmol) and pivalalde-
hyde 861 mg (10.0 mmol) were used in this reaction to
give 240 mg (yield: 94%) of the compound14 according to
the protocol described in general procedure (condition: rt/
10 min). White solids. Mp 210±2128C (lit. 208±2098C). 1H
0
NMR (CDCl3); ppm: 7.50±7.83 (2H0, m, C6 and C6 ±H),
0
7.83±8.17 (4H, m, C5, C7, C5 and C7 ±H), 8.17±8.42 (2H,
0
0
4.1.12. 2,2-Dimethyl-1-(1-isoquinolinyl)-1-propanol (18).
Lithium n-butanetellurolate (2.20 mmol), 1-bromoisoquino-
line (12) 320 mg (1.54 mmol), n-butyllithium (1.69 mmol)
and pivalaldehyde 662 mg (7.69 mmol) were used in this
reaction to give 118 mg (yield: 36%) of the compound
and 75 mg (yield: 38%) of isoquinoline according to the
protocol described in general procedure (condition: re¯ux/
24 h). White needles (recryst. from hexane). Mp 106±
m, C8 and C8 ±H), 9.54 (2H, s, C2 and C2 ±H).
4.1.17. 2,2-Dimethyl-1-(2-methyl-9-phenyl-9H-purin-8-
yl)-1-propanol
(25).
Lithium
n-butanetellurolate
(1.10 mmol), 6-chloro-2-methyl-9-phenyl-9H-purine (23)
245 mg (1.00 mmol), n-butyllithium (1.10 mmol) and
pivalaldehyde 431 mg (5.00 mmol) were used in this
reaction to give 110 mg (yield: 37%) of the compound
and 111 mg (yield: 29%) of 26 according to the protocol
described in general procedure (condition: rt/30 min). Pale-
yellow powder (recryst. from hexane±ethyl acetate). Mp
1
t
1078C. H NMR (CDCl3); ppm: 0.95 (9H, s, Bu), 4. 50
(1H, d, J8.8 Hz, ±OH), 5.26 (1H, d, J8.8 Hz, ±CH±),
7.42±7.97 (4H, m, aromatic-H), 8.06±8.31 (1H, m,